These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 16309781

  • 1. Wet age-related macular degeneration.
    Kulkarni AD, Kuppermann BD.
    Adv Drug Deliv Rev; 2005 Dec 13; 57(14):1994-2009. PubMed ID: 16309781
    [Abstract] [Full Text] [Related]

  • 2. New approaches in the management of choroidal neovascular membrane in age-related macular degeneration.
    Verma L, Das T, Binder S, Heriot WJ, Kirchhof B, Venkatesh P, Krebs I, Stolba U, Jahn C, Feichtinger H, Kellner L, Krugluger H, Pawelka I, Frohner U, Kruger A, Li W, Tewari HK.
    Indian J Ophthalmol; 2000 Dec 13; 48(4):263-78. PubMed ID: 11340884
    [Abstract] [Full Text] [Related]

  • 3. Treatment of neovascular age-related macular degeneration: past, present and future directions.
    Smith BT, Joseph DP, Grand MG.
    Curr Opin Ophthalmol; 2007 May 13; 18(3):240-4. PubMed ID: 17435433
    [Abstract] [Full Text] [Related]

  • 4. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).
    Rasmussen H, Chu KW, Campochiaro P, Gehlbach PL, Haller JA, Handa JT, Nguyen QD, Sung JU.
    Hum Gene Ther; 2001 Nov 01; 12(16):2029-32. PubMed ID: 11727737
    [Abstract] [Full Text] [Related]

  • 5. [The molecular mechanisms of neovascular age-related macular degeneration].
    Miller DW, Joussen AM, Holz FG.
    Ophthalmologe; 2003 Feb 01; 100(2):92-6. PubMed ID: 12589451
    [Abstract] [Full Text] [Related]

  • 6. Metabolic physiology in age related macular degeneration.
    Stefánsson E, Geirsdóttir A, Sigurdsson H.
    Prog Retin Eye Res; 2011 Jan 01; 30(1):72-80. PubMed ID: 20951826
    [Abstract] [Full Text] [Related]

  • 7. Visual function in patients with choroidal neovascularization resulting from age-related macular degeneration: the importance of looking beyond visual acuity.
    Fletcher DC, Schuchard RA.
    Optom Vis Sci; 2006 Mar 01; 83(3):178-89. PubMed ID: 16534460
    [Abstract] [Full Text] [Related]

  • 8. Guidance for the treatment of neovascular age-related macular degeneration.
    Schmidt-Erfurth UM, Richard G, Augustin A, Aylward WG, Bandello F, Corcòstegui B, Cunha-Vaz J, Gaudric A, Leys A, Schlingemann RO, European Society for Retina Specialists' Guidelines Committee (EURETINA).
    Acta Ophthalmol Scand; 2007 Aug 01; 85(5):486-94. PubMed ID: 17655610
    [Abstract] [Full Text] [Related]

  • 9. The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration.
    Grisanti S, Tatar O.
    Prog Retin Eye Res; 2008 Jul 01; 27(4):372-90. PubMed ID: 18621565
    [Abstract] [Full Text] [Related]

  • 10. Macular microcirculation blood flow in patients with age related macular degeneration treated with photodynamic therapy and transpupillary thermotherapy.
    Kubicka-Trzaska A.
    Klin Oczna; 2007 Jul 01; 109(4-6):138-41. PubMed ID: 17725271
    [Abstract] [Full Text] [Related]

  • 11. Surgical treatment of age-related macular degeneration.
    Skaf AR, Mahmoud T.
    Semin Ophthalmol; 2011 May 01; 26(3):181-91. PubMed ID: 21609231
    [Abstract] [Full Text] [Related]

  • 12. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.
    Ferrara N, Damico L, Shams N, Lowman H, Kim R.
    Retina; 2006 Oct 01; 26(8):859-70. PubMed ID: 17031284
    [Abstract] [Full Text] [Related]

  • 13. Age-related macular degeneration: a practical approach to a challenging disease.
    Bourla DH, Young TA.
    J Am Geriatr Soc; 2006 Jul 01; 54(7):1130-5. PubMed ID: 16866687
    [Abstract] [Full Text] [Related]

  • 14. Transpupillary thermotherapy for the treatment of choroidal neovascularization in age-related macular degeneration in Taiwan.
    Tsai TH, Yang CM, Yang CH, Ho TC, Huang JS, Chen MS.
    Eye (Lond); 2007 Jun 01; 21(6):721-6. PubMed ID: 16543926
    [Abstract] [Full Text] [Related]

  • 15. Antiangiogenic approaches to age-related macular degeneration today.
    Bressler NM.
    Ophthalmology; 2009 Oct 01; 116(10 Suppl):S15-23. PubMed ID: 19800535
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of choroidal neovascularization by adenovirus-mediated delivery of short hairpin RNAs targeting VEGF as a potential therapy for AMD.
    Cashman SM, Bowman L, Christofferson J, Kumar-Singh R.
    Invest Ophthalmol Vis Sci; 2006 Aug 01; 47(8):3496-504. PubMed ID: 16877421
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Age-related macular degeneration.
    Brucker AJ.
    Retina; 2009 Jun 01; 29(6 Suppl):S2-4. PubMed ID: 19553791
    [Abstract] [Full Text] [Related]

  • 19. Emerging therapies for neovascular age-related macular degeneration: state of the art.
    Donati G.
    Ophthalmologica; 2007 Jun 01; 221(6):366-77. PubMed ID: 17947822
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.